Padraic O'Malley, MSc, MD, FRCSC - Research

Research at a glance

Top areas of exploration

Urinary Bladder Neoplasms , 12 publications
Kidney Neoplasms , 8 publications
Cystectomy , 8 publications
Robotic Surgical Procedures , 7 publications

Research activity

36 publications

852 citations

Why is this important?

Active clinical trials

Comparing Immunotherapy-Based Drug Combination Therapy w/ or w/o surgery for mRCC (PROBE)

This phase III trial compares the effect of adding surgery to a standard of care immunotherapy-based drug combination versus a standard of care immunotherapy-based drug combination alone in treating patients with kidney cancer that has spread to鈥�

Investigator: Padraic O'Malley
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

Intravesical BCG vs GEMDOCE in NMIBC (BRIDGE)

The study hypothesis is that BCG na茂ve non-muscle invasive bladder cancer (NMIBC) patients treated with intravesical Gemcitabine + Docetaxel (GEMDOCE) will result in a non-inferior event-free survival (EFS) compared to standard treatment with鈥�

Investigator: Padraic O'Malley
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

My publications

36 publications

2024

Approaches to Treating High Risk and Advanced Renal Cell Carcinoma (RCC): Key Trial Data That Impacts Treatment Decisions in the Clinic.

Research and reports in urology

鈥�

2024

Efficacy of BCG for non-muscle invasive bladder cancer following nephroureterectomy for upper tract urothelial carcinoma.

Urologic oncology

鈥�

2023

A Pilot Study on Hyperthermic Intraperitoneal Chemotherapy after Radical or Partial Cystectomy with Pelvic Lymph Node Dissection for High-risk Muscle-invasive Bladder Cancer.

European urology

鈥�

2023

Editorial Comment.

The Journal of urology

鈥�

2023

Hyaluronan Metabolism in Urologic Cancers.

Advanced biology

鈥�

BOB体育